← Back to all news
← Terug naar alle nieuws
← Back to all news (FR)

30/04/2021 - miDiagnostics today announced the launch of the holy grail for COVID-19 testing: an ultra-fast PCR test for point-of-care use

30/04/2021 - miDiagnostics today announced the launch of the holy grail for COVID-19 testing: an ultra-fast PCR test for point-of-care use

30/04/2021 - miDiagnostics today announced the launch of the holy grail for COVID-19 testing: an ultra-fast PCR test for point-of-care use

miDiagnostics, a spin-off of the world-leading nano-electronics research center imec, today announced the launch of the holy grail for COVID-19 testing: an ultra-fast PCR test for point-of-care use.

Flemish entrepreneurs-investors Marc Coucke, Urbain Vandeurzen and Michel Akkermans provide miDiagnostics with sufficient additional funding to support its transition to a commercial company. The management is reinforced with Katleen Verleysen as experienced CEO and Hans Vanderwegen as experienced COO.

miDiagnostics, a spin-off of the world-leading nano-electronics research center imec, today announced the launch of the holy grail for COVID-19 testing: an ultra-fast PCR test for point-of-care use.

Flemish entrepreneurs-investors Marc Coucke, Urbain Vandeurzen and Michel Akkermans provide miDiagnostics with sufficient additional funding to support its transition to a commercial company. The management is reinforced with Katleen Verleysen as experienced CEO and Hans Vanderwegen as experienced COO.

miDiagnostics, a spin-off of the world-leading nano-electronics research center imec, today announced the launch of the holy grail for COVID-19 testing: an ultra-fast PCR test for point-of-care use.

Flemish entrepreneurs-investors Marc Coucke, Urbain Vandeurzen and Michel Akkermans provide miDiagnostics with sufficient additional funding to support its transition to a commercial company. The management is reinforced with Katleen Verleysen as experienced CEO and Hans Vanderwegen as experienced COO.